Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01951690 |
Title | Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Verastem, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Colorado Cancer Center, Anschutz Medical Campus | Denver | Colorado | 80045 | United States | Details | |
Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | United States | Details | |
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | United States | Details | |
Washington University School of Medicine | St. Louis | Missouri | 63110 | United States | Details | |
Knight Cancer Institute, Oregon Health and Science University | Portland | Oregon | 97239 | United States | Details | |
University of Pittsburgh Medical Center Cancer Center | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
University of Texas Southwestern Medical Center | Dallas | Texas | 75390-8852 | United States | Details | |
The University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229-3900 | United States | Details |